News Releases

Boston Scientific Announces Conference Call Discussing First Quarter 2018 Financial Results

Mar 26, 2018

MARLBOROUGH, Mass., March 26, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2018 on Wednesday, April 25, 2018 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on Wednesday, April 25, 2018, prior to the conference call.

Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)

A live webcast of the conference call will be available on the Investor Relations section of the website at investors.bostonscientific.com.

A replay of the webcast will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the meeting.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:                                                                   

Investors:

Kate Haranis                                                            

Susie Lisa, CFA

508-683-6585 (office)                                            

508- 683-5565 (office)

Media Relations                                                     

Investor Relations

Boston Scientific Corporation                                  

Boston Scientific Corporation

Kate.Haranis@bsci.com                                         

BSXInvestorRelations@bsci.com

 

SOURCE Boston Scientific Corporation